Investment Thesis — Healthpeak Properties, Inc.
The market misprices DOC by fixating on its elevated P/E and perceived interest rate sensitivity, failing to fully appreciate the defensive, long-term growth profile of its specialized healthcare real estate portfolio. This overlooks the inelastic demand from an aging demographic and the strategic value of its life science assets.
Catalysts
- Federal Reserve interest rate cuts
- Strong FFO/AFFO growth driven by life science and medical office demand
- Strategic portfolio optimization or M&A activity
Risk Factors
- Prolonged elevated interest rates
- Unexpected downturn in healthcare spending or regulatory changes
- Increased tenant defaults or higher vacancy rates in key segments
Key Debates
Fwd P/E multiple compresses to 30x by Q4 as earnings fail to recover
Revenue growth turns positive by H2 offsetting dispositions
Net Margin expands to 5% by Q3, justifying current P/E